Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-20,903
Closed -$1.27M 149
2018
Q2
$1.27M Sell
20,903
-62,667
-75% -$3.8M 0.46% 73
2018
Q1
$5.01M Buy
83,570
+3,250
+4% +$196K 1.82% 7
2017
Q4
$4.58M Buy
80,320
+6,798
+9% +$377K 2.05% 9
2017
Q3
$3.92M Buy
73,522
+1,523
+2% +$76.4K 2.07% 8
2017
Q2
$3.5M Sell
71,999
-409
-0.6% -$18.5K 1.98% 7
2017
Q1
$3.22M Buy
72,408
+293
+0.4% +$12.7K 1.89% 9
2016
Q4
$2.77M Buy
72,115
+8,294
+13% +$329K 1.74% 11
2016
Q3
$2.7M Sell
63,821
-52,285
-45% -$2.24M 1.87% 9
2016
Q2
$4.56M Buy
+116,106
New +$4.62M 1.57% 7
2016
Q1
Sell
-4,936
Closed -$222K 166
2015
Q4
$222K Sell
4,936
-40
-0.8% -$1.77K 0.2% 107
2015
Q3
$200K Buy
+4,976
New +$235K 0.17% 116

Other funds holding ABT

Palo Capital's ABT Position: Q3 2018 in Review

Palo Capital sold out of Abbott (ABT) in Q3 2018, closing a stake of 20,903 shares — an estimated $1.27M sold.

Palo Capital first reported a position in ABT in Q3 2015 and held it in 11 quarters. The position peaked at $5.01M in Q1 2018. 1,869 funds tracked by Wall St. Rank hold ABT as of Q3 2018.

  • Palo Capital reported no remaining Abbott position as of Q3 2018 after selling out during the quarter.
  • Palo Capital sold 20,903 Abbott shares in Q3 2018, an estimated $1.27M.
  • Palo Capital first reported a position in Abbott in Q3 2015 and held it in 11 quarters.
  • Palo Capital's Abbott position peaked at $5.01M in Q1 2018.
  • 1,869 funds tracked by Wall St. Rank held Abbott as of Q3 2018.

Based on Palo Capital's 13F filing for Q3 2018, filed 25 Oct 2018.